Melanoma differentiation-associated gene-7/interleukin-24 (mda-7/IL-24), a cytokine belonging to the IL-10 family, selectively induces apoptosis in cancer cells without harming normal cells by promoting an endoplasmic reticulum (ER) stress response. The precise molecular mechanism by which the ER stress response culminates in cell death requires further clarification. The present study shows that in prostate carcinoma cells, the mda-7/IL-24-induced ER stress response causes apoptosis by translational inhibition of the antiapoptotic protein myeloid cell leukemia-1 (Mcl-1). Forced expression of Mcl-1 blocked mda-7/IL-24 lethality, whereas RNA interference or gene knockout of Mcl-1 markedly sensitized transformed cells to mda-7/IL-24. Mcl-1 downregulation by mda-7/IL-24 relieved its association with the proapoptotic protein Bak, causing oligomerization of Bak and leading to cell death. These observations show the profound role of the Bcl-2 protein family member Mcl-1 in regulating cancer-specific apoptosis induced by this cytokine. Thus, our studies provide further insights into the molecular mechanism of ER stress-induced cancer-selective apoptosis by mda-7/ IL-24. As Mcl-1 is overexpressed in the majority of prostate cancers, mda-7/IL-24 might provide an effective therapeutic for this disease. Cancer Res; 70(12); 5034-45. ©2010 AACR.
Introduction
Prostate cancer is the most common cancer and the second leading cause of cancer-related death in men in the United States (1) . It is estimated that 1 man in 6 will be diagnosed with prostate cancer during his lifetime. Thus, it is imperative to develop more effective therapeutic approaches for late-stage prostate cancer (2) .
Using subtraction hybridization combined with induction of cancer cell terminal differentiation, our laboratory cloned melanoma differentiation-associated gene-7/interleukin-24 (mda-7/IL-24; ref. 3) , a novel member of the IL-10-related cytokine gene family (4, 5) . Subsequent studies documented that mda-7/IL-24 has almost ubiquitous antitumor properties in vitro and in vivo, leading to its entry into the clinic, where its safety and clinical efficacy, when administered by adenovirus (Ad.mda-7; INGN 241), was observed in a phase I clinical trial in humans with advanced carcinomas and melanomas (6) (7) (8) (9) . Its mode of action involves preferential induction of apoptosis in cancer cells while exerting no discernible toxic effects toward normal cells (10) (11) (12) (13) (14) (15) (16) by eliciting potent "antitumor bystander activity" as a consequence of autocrine secretion (14, 17) .
On ectopic expression of mda-7/IL-24 by an adenovirus, the MDA-7/IL-24 protein interacts with the endoplasmic reticulum (ER) chaperone protein BiP/GRP78 and initiates a cascade of "unfolded protein response" (UPR) events in tumor cells that culminate in apoptosis (18) (19) (20) . Several well-known apoptosis-related molecules play critical roles in UPR-mediated apoptosis, among them myeloid cell leukemia-1 (Mcl-1), and have been reported to be downregulated/inactivated (21, 22) . Mcl-1 plays a pivotal role in cancer cell survival, including that of prostate cancer cells, suggesting involvement of this gene in prostate carcinogenesis (23) . Depletion of Mcl-1 using antisense oligonucleotides rapidly triggers apoptosis in leukemia cells (24) . On the other hand, overexpression of Mcl-1 protects cells from apoptosis induced by a variety of stress-promoting agents, including UV, etoposide, staurosporine, and actinomycin D (25, 26) .
In this study, we report that in prostate cancer cells, mda-7/IL-24 potently induces apoptosis in association with a pronounced reduction in Mcl-1 expression followed by Bak activation. Moreover, prevention of mda-7/IL-24-mediated Mcl-1 downregulation by ectopic expression of Mcl-1 markedly diminishes mda-7/IL-24-induced mitochondrial injury and apoptosis. Finally, the present results indicate that mda-7/IL-24 downregulates Mcl-1 expression through inhibition of translation, rather than through a transcriptional mechanism. The present study highlights Mcl-1 as a potential target for therapeutic intervention in prostate cancer and identifies mda-7/IL-24 as a potent translational regulator of this critical cancer survival molecule.
Materials and Methods

Cells and stable clones
M12 and M2182 (progressed prostate cancer cells obtained from Dr. Joy Ware, VCU School of Medicine, Richmond, VA), DU-145, PC-3, P69, and mouse embryonic fibroblasts (MEF) were cultured as described (27, 28) . DU-145 ectopically expressing Mcl-1 clones were generated as described previously (27) .
Assessment of cell death and apoptosis
Apoptotic cells were identified and quantified by Annexin V-fluorescein isothiocyanate staining (16) , and cell death was quantified by trypan blue dye exclusion assays (29) .
Quantitative real-time PCR
DU-145 cells were infected with Ad.vec or Ad.mda-7 for the indicated period, after which they were lysed and total RNA was extracted using the RNeasy mini kit (Qiagen). Quantitative real-time PCR analysis for Mcl-1 was performed as previously described (30) .
Transient transfections and reporter gene assays, immunoprecipitation, and immunoblotting
Transfections used Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol, and the plasmid constructs have been described previously (30, 31) . Reporter gene assays for Mcl-1 were carried out as previously described (31) . Immunoprecipitation and immunoblotting were performed as described previously (31) . The primary antibodies used in this study are Mcl-1, ubiquitin, BiP/GRP78, Bak, phosphorylated protein kinase R-like ER kinase (phospho-PERK; Santa Cruz Biotechnology, Inc.); poly(ADP-ribose) polymerase (PARP; Biomol Research Laboratories); Bcl-xL, total and phospho-ERK1/2 (Thr-202/Tyr-204), phospho-4EBP1 (Ser65), phospho-eIF4E (Ser209), phospho-eIF4G (Ser1108), total and phospho-p38 (Thr180/Tyr182), total and phospho-Akt (Thr183/Tyr185), total and phospo-eIF4G, total and phosphoeIF4E, phospho-eIF2 (Cell Signaling Technology); MDA-7/ IL-24 (Gen Hunter Corporation); anti-EF1α (Upstate Biotechnology); GRP94 (1:1,000, Sigma); and Bak Ab-1 (Calbiochem).
Mcl-1 protein stability and isolation of polysomes DU-145 cells were infected with Ad.vec or Ad.mda-7 at 100 plaque-forming units (pfu)/cell for 16 hours, and pulse chase was performed, as previously described (30) , for the indicated times. Polysomes were purified (32) ) were injected s.c. in 100 μL of PBS in the left flank of male athymic nude mice, and xenograft studies were conducted as described previously (33) . Formalin-fixed and paraffin-embedded specimens were sectioned 3-to 4-μm thick, and immunohistochemistry was done as described previously (33) .
Detection of Bak and Bax activation
For Bak oligomerization studies, DU-Mcl-1-8 and pcDNA3.1-6 cells were treated with the indicated titer of Ad.vec or Ad.mda-7 for 48 hours, and Bak oligomerization studies were performed (34) . Bak and Bax activation were detected by flow cytometry (35) .
Proteasome activity assays
DU-145 cells were infected with Ad.vec or Ad.mda-7, and lysates were collected after 12, 24, 48, and 72 hours. Proteasomal activity was measured using the 20S Proteasome Activity Assay Kit (Millipore Corporation) according to the manufacturer's protocol.
Statistical analysis
Data are represented as the mean ± SD and analyzed for statistical significance using one-way ANOVA followed by Newman-Keuls test as a post hoc test. A P value of <0.05 was considered significant.
Results
Mcl-1 is overexpressed in human prostate carcinogenesis
We first established elevated expression of Mcl-1 in prostate cancer cell lines and patient-derived samples. P69 is a normal human prostate epithelial cell line immortalized by SV40 T/t antigen, M2182 is a tumorigenic but nonmetastatic P69 variant, and M12 is a tumorigenic and metastatic variant of P69, whereas PC-3 and DU-145 cells are highly aggressive tumorigenic patient-derived prostate carcinoma cell lines. Low-level Mcl-1 expression was detected in P69 cells, whereas robust expression of Mcl-1 was detected in M12, DU-145, and PC-3 cells (Fig. 1A) . In nonmetastatic M2182 cells, a lower level of Mcl-1 expression was evident compared with M12, DU-145, and PC-3 cells. These findings were extended using two tissue microarrays (IMT-01291 and IMT-01286) that were immunostained using anti-Mcl-1 antibody. Very little or no Mcl-1 immunostaining was detected in the 17 normal prostate biopsy samples (Supplementary Table S1 ), whereas significant Mcl-1 staining was observed in prostate cancer samples (Fig. 1B-F Fig. 2A and B) and induction of apoptosis. At 48 hours, when Mcl-1 was extinguished, 43% of cells were apoptotic as detected by Annexin V-FITC/PI staining and PARP cleavage ( Fig. 2A) . Additionally, in DU-145 cells, the levels of BiP/GRP78, GRP94, activation of PERK, and eukaryotic initiation factor 2-α (p-eIF2α [Ser 51 ]) were increased in a time-dependent manner, which correlated with decreased Mcl-1 protein levels ( Fig. 2A) . On the other hand, infection of DU-145 cell with Ad.GFP or Ad.LUC (100 pfu/cell) did not result in downregulation of Mcl-1 or induction of apoptosis (data not shown). In DU-145 cells, transient expression of a dominant-negative PERK or dominant-negative eIF2α protected from Ad.mda-7-mediated downregulation of Mcl-1 as well as apoptosis ( Fig. 2C and D) . In PC-3 cells, infection with a tropism-modified adenovirus Ad5/3.mda-7 (33) resulted in significant accumulation of MDA-7/IL-24 protein with a concomitant decrease in Mcl-1 and induction of apoptosis (Fig. 2E ). In P69 normal immortal human prostate epithelial cells, Mcl-1 downregulation was not observed on infection with Ad.mda-7, and apoptosis was not induced (Fig. 2F ). (Fig. 3B) , was used for further experiments.
To determine if the in vitro resistance of DU-Mcl-1-8 to Ad.mda-7 infection also translated to the in vivo setting, DU-Mcl-1-8 and DU-pcDNA3.1 tumors were established in the left flanks of athymic nude mice. After palpable tumors of ∼75 mm 3 developed, in ∼7 to 10 days, the animals received seven intratumoral injections over a 4-week period, with 4.5 × 10 8 pfu of Ad.vec or Ad.mda-7. In the DU-Mcl-1-8 xenograft model, a modest antitumor growth-inhibitory effect was seen with injection of Ad.mda-7 as evident from measurement of both tumor size and weight ( Fig. 3D and E ). In contrast, Ad.mda-7 exhibited a dramatic inhibition in growth of the DU-pcDNA3.1 tumors. In both the DU-Mcl-1-8 and pcDNA3.1 xenografts, infection with Ad.mda-7 generated a significant amount of MDA-7/IL-24 protein; however, increased terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) staining and decreased expression of Ki-67 were observed only in DU-pcDNA3.1 xenografts. In DU-Mcl-1-8 xenografts, no significant increase in TUNEL staining and no decrease in Ki-67 staining were observed (Fig. 3F ).
Mcl-1 downregulation promotes activation of Bak
One of the mechanisms by which Mcl-1 opposes apoptosis is by binding and sequestering the proapoptotic protein Bak (35) . Therefore, we investigated Bak activation following infection with Ad.vec or Ad.mda-7 in the DU-Mcl-1-8 and DU-pcDNA3.1 clones. Total Bak levels were unaffected in either clone by infection with Ad.mda-7 (Fig. 4A) . Immunoprecipitation and flow cytometric analysis using an activated form of anti-Bak antibody (clone Ab-1) revealed that in DU-pcDNA3.1 cells, activated Bak appeared at 48 hours after Ad.mda-7 infection. In contrast, in DU-Mcl-1-8 cells, significantly less Bak activation was observed ( Fig. 4A and B) . Correlating with these data, 48 hours after infection with Ad.mda-7, Bak oligomers were readily observed in DU-pcDNA3.1 cells but not in DU-Mcl-1-8 cells (Fig. 4C) . Similarly, the faster migrating intramolecular cross-linked species of Bak (inactive form of Bak) was only observed in Ad.vec-infected DU-pcDNA3. (Fig. 4D) . Moreover, in DU-pcDNA3.1 cells, the pan-caspase inhibitor z-VAD-FMK was ineffective in preventing Mcl-1 downregulation caused by Ad.mda-7 infection. Furthermore, in DU-145, a Bak siRNA significantly protected cells from Ad.mda-7-induced apoptosis ( Fig. 4E ; *, P < 0.05). As DU-145 is a Bax-null cell, we also evaluated Bax and Bak activation using flow cytometry in PC-3 cells, which express both proapoptotic proteins ( Supplementary Fig. S1A and B) . Infection of PC-3 cells with Ad.5/3.mda-7 resulted in activation of Bak (D ∼ 0.21) to a greater extent than Bax (D ∼ 0.10).
RNA interference or gene knockout of Mcl-1 dramatically sensitizes cells to mda-7/IL-24-mediated toxicity
To further evaluate the role of Mcl-1 in mda-7/IL-24-mediated cytotoxicity, both a siRNA strategy and a gene knockout approach were used. DU-145 cells were transiently transfected with a siRNA against Mcl-1 (Fig. 5A, inset) . Mcl-1 inhibition dramatically sensitized DU-145 cells to Ad.mda-7 lethality both at high and low doses (50 or 100 pfu/cell; Fig. 5A (27) . Similarly, Ha-ras-transfected wt MEFs were sensitive to Ad.mda-7. However, Ha-ras-transfected Bax −/− , Bak −/− , and Bax −/− /Bak −/− (double knockout) MEFs displayed significant resistance (*, P < 0.05) to Ad.mda-7 infection (Fig. 5C ).
mda-7/IL-24 downregulates Mcl-1 through inhibition of Mcl-1 translation
We next analyzed the molecular mechanism of Mcl-1 downregulation by Ad.mda-7. Infection of DU-145 cells with Ad.mda-7 had no significant effect on luciferase driven by a Mcl-1 promoter or total Mcl-1 mRNA level (P > 0.05) even after 48 hours or onward (Fig. 6A, top left and right) . In addition, inhibition of transcription using actinomycin D (1 μg/mL) resulted in a decrease in Mcl-1 protein levels, and infection with Ad.mda-7 resulted in a further decline at 12 hours (Fig. 6A, bottom) , suggesting an alternative, transcription-independent mechanism of Mcl-1 downregulation by mda-7/IL-24. Immunoprecipitation followed by immunoblot analysis revealed no major changes in Mcl-1 ubiquitination in Ad.mda-7-infected cells even after 48 hours (Fig. 6B, top) . Further, Ad.mda-7 infection did not enhance proteasomal activity even after 48 hours (Fig. 6C) . Furthermore, blocking the proteasome system with MG132 resulted in a time-dependent accumulation of Mcl-1, which was completely abrogated by concomitant Ad.mda-7 infection (Fig. 6B, bottom left) . Moreover, in the absence of MG132, mda-7/IL-24 largely downregulated total Mcl-1 levels, whereas MG132 resulted in a clear increase by opposing proteasomal degradation. Infection with Ad.mda-7 and administration of MG132 resulted in no change in total Mcl-1 levels, indicating that mda-7/IL-24 blocks MG132-mediated Mcl-1 accumulation by preventing new synthesis probably due to inhibition of Mcl-1 translation (Fig. 6B,  bottom right) . Furthermore, infection with Ad.mda-7 resulted in suppression of eIF4E phosphorylation, which was evident from 18 hours after infection and onward (Fig. 6D) . Levels of total eIF4E protein remained unchanged following Ad.mda-7 infection. The levels of both total and phosphorylated eIF4G were increased following infection with Ad.mda-7, whereas phosphorylation of the eIF4E-binding protein-1 declined at later time points. Furthermore, when we analyzed the newly synthesized 8 (1,6-bismaleimidohexane) and DU-pcDNA3.1 cells were infected with the indicated pfu/cell of Ad.vec and Ad.mda-7 for 24 h in the absence or presence of 25 μmol/L of z-VAD-FMK, after which cells were lysed and subjected to immunoprecipitation using anti-Bak and then immunoblotted with anti-Mcl-1. For comparison, the rightmost lanes (designated as "Lysate") were loaded with whole-cell lysates.E, DU-145 cells were transiently transfected with either control siRNA or Bak siRNA for 24 h, after which cells were lysed and subjected to immunoblotting analysis (inset). After transfection with control siRNA or Bak siRNA, cells were infected with the 100 pfu/cell of Ad.vec or Ad.mda-7 for 48 h, after which the percentage of apoptosis was determined by flow cytometry after Annexin V-FITC/PI staining. Bars, SD (n = 3; *, P < 0.05).
might block Mcl-1 protein synthesis rather than affect protein turnover (Fig. 6E, top) . Finally, we determined Mcl-1 mRNA association with polysomes on infection of DU-145 cells with Ad.vec or Ad.mda-7. After 30 hours of infection, the Ad.mda-7-infected cells exhibited reduced Mcl-1 mRNA binding to polysomes compared with Ad.vec-infected cells (Fig. 6E, bottom) .
Discussion
Among the members of this Bcl-2 gene family, Mcl-1 plays a central role in prostate carcinogenesis (36) . For example, a study examining 64 cases of prostate adenocarcinoma with different Gleason scores and 24 cases of prostatic intraepithelial neoplasia (PIN) found that the percentage of SD (n = 3). *, P < 0.05 with the Ad.mda-7 50 pfu/cell-infected group of wild-type MEFs; **, P < 0.05 with the Ad.mda-7 100 pfu/cell-infected group of wild-type MEFs. MDA-7/IL-24 expression was detected from the lysates (left inset).
Mcl-1-positive cells was higher in tumors with Gleason grades 8 to 10 than in PIN or lower-grade tumors (23) . These data are consistent with the results of our study; however, we did not observe any correlation between increased expression of Mcl-1 and stages of the disease. These results indicate that Mcl-1 might be more essential for tumor cell survival in the initial stages of carcinogenesis rather than playing any direct role in cancer progression. Elimination of Mcl-1 has been shown to be required for apoptosis induction in response to a number of ER stimuli, including thapsigargin (22, 31) and sorafenib (31) . Downregulation of Mcl-1 in ER-stressed cells is a consequence of stress-induced phosphorylation of eIF2α at Ser51 (22) . This interpretation is supported by the observations that when DU-145 cells were transfected with a dominant-negative eIF-2α or a dominant-negative PERK, mda-7/IL-24-mediated induction of apoptosis and Mcl-1 downregulation were inhibited. It should be noted that PERK activation is generally considered a marker for ER stress and UPR, and necessary for activation of eIF2α (37) . PERK is an ER-resident type I transmembrane protein whose NH 2 -terminal luminal domain is sensitive to the upstream ER stress signal and whose COOH-terminal cytoplasmic domain directly phosphorylates eIF2α. Under conditions of ER stress, BiP/GRP78 increases the load of ER client proteins, whereas loss of BiP/GRP78 binding correlates with oligomerization, trans-autophosphorylation, and activation of downstream signaling by PERK (37, 38) . It is worth noting that in GBM cells and transformed fibroblasts, MDA-7/IL-24-activated PERK and PERK −/− transformed fibroblasts or GBM cells expressing a dominant-negative PERK Cells were incubated for 6 h and then infected with 100 pfu/cell of Ad.vec or Ad.mda-7 for the indicated time, after which the activity of firefly and Renilla luciferase was monitored. Bars, SD (n = 3). Top right, DU-145 cells were treated as above, after which the total RNA was isolated and Mcl-1 mRNA was quantified using real-time PCR. Bars, SD (n = 3). Bottom, DU-145 cells were infected with 100 pfu/cell of Ad.vec or Ad.mda-7 for 2 h and then treated with 1 μg/mL actinomycin D (Act D) for 6 or 12 h, after which cell lysates were prepared and subjected to Western blotting to monitor Mcl-1 protein levels. B, top, DU-145 cells were treated with the indicated amount of MG132 or infected with 100 pfu/cell of Ad.vec or Ad.mda-7 for the designated periods, after which cells were lysed and subjected to immunoprecipitation using anti-Mcl-1 antibodies and then immunoblotted with anti-ubiquitin or Mcl-1 antibodies. Bottom left, DU-145 cells infected with Ad.vec or Ad.mda-7 at 100 pfu/cell were exposed to 1 μmol/L MG132 for the designated periods and subjected to Western blot analysis to monitor Mcl-1 protein levels. Bottom right, DU-145 cells were exposed to 1 μmol/L MG132 or 100 pfu/cell Ad.vec alone, simultaneously treated with 1 μmol/L MG132 and infected with 100 pfu/cell of Ad.mda-7, or infected with Ad.mda-7 (100 pfu/cell) for 6 h before adding 1 μmol/L MG132. After 24 h of treatment, cells were lysed and Western blotting was performed as above. C, DU-145 cells were infected with 100 pfu/cell of Ad.vec or Ad.mda-7 for the indicated times, lysates were collected, and proteasome activity was measured as described in Materials and Methods. Bars, SD (n = 3). D, DU-145 cells were infected with 100 pfu/cell of Ad.vec or Ad.mda-7 for the indicated periods, after which protein lysates were prepared and subjected to Western blotting using the indicated antibodies. E, top, DU-145 cells were infected with 100 pfu/cell of Ad.vec or Ad.mda-7 for 16 h and then cells were labeled with [ were resistant to MDA-7/IL-24-induced killing. Furthermore, overexpression of the PERK chaperone BiP/GRP78 blocked mda-7/IL-24-induced PERK activation and cell killing (29) . BiP/GRP78 interacts physically with MDA-7/IL-24 in prostate cancer cells, and hence is considered a primary target for MDA-7/IL-24 in these cells (18) . Our findings rule out a significant role for altered Mcl-1 transcription, mRNA stability, or enhanced proteasomal degradation activity of Mcl-1 when DU-145 cells were infected with Ad.mda-7. The polysomal association of Mcl-1 mRNA provided evidence of marked inhibition of Mcl-1 translation following infection with Ad.mda-7. Diminished Mcl-1 translation has been implicated in Mcl-1 downregulation in several systems, including HeLa cells exposed to UV (39) and BAY 43-9006-mediated lethality in both U937 and K562 cells (30) . Translation of most mRNAs is dependent on the cap structure m7-GTP, which is found at the 5′ terminus of all cellular eukaryotic mRNAs. The cap-binding protein eIF4E represents the rate-limiting member of the eIF4F complex and binds directly to the 5′-terminal m7-GTP cap, resulting in recruitment of ribosomes to the 5′-end of the mRNA transcripts (40) . Infection with Ad.mda-7 results in a marked decrease of eIF4E protein phosphorylation, and an increase in both total and phosphorylated eIF4G, which could be a possible reason for reduced polysomal binding of Mcl-1 mRNA.
In summary, mda-7/IL-24 induces transformed cellselective antitumor activity through ER stress by inhibiting the translation of Mcl-1 protein in prostate cancer, which leads to activation of Bak. Earlier, we reported the importance of Bcl-X L in protecting against mda-7/IL-24 lethality (27) . Both Bcl-X L and Mcl-1 can sequester Bak (35) ; however, it is important to note that ectopic expression of mda-7/Il-24 can moderately downregulate Bcl-X L while, at the same time point, Mcl-1 disappeared completely (Fig. 7A) . The functional redundancy of these two antiapoptotic proteins depends on the fact that only one of them is tightly regulated by the therapeutic treatment of mda-7/IL-24 (Fig. 7B) . Overall, our present study highlights the possibility that mda-7/IL-24 may cooperate synergistically with Mcl-1 small-molecule inhibitors to induce cancer cell death, which is an area for future investigation.
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